President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Jerry Keybl, senior vice-president, Biopharma Products and Strategy, Avantor, discusses innovations in biomanufacturing and ...

President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Ocular Therapeutix, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

The US initiated a Section 232 investigation on pharmaceutical products in April, purportedly to verify the impact of imports ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...